Condition: Gynecologic Cancer · Frailty · Oncology · Sponsor: Population Health Research Institute
FARGO is a prospective cohort study that aims to determine the performance of preoperative frailty assessment based on the Frailty Phenotype (FP), compared to a perioperative cardiovascular risk assessment based on the combination of preoperative Revised Cardiac Risk Index (RCRI), age and occurrence of myocardial injury after noncardiac surgery (MINS), in predicting the composite of all-cause death or new disability at 6 months after surgery in patients aged 55 or older. Patients will have confirmed or suspected gynecologic cancer, undergoing cytoreductive or high-risk surgery with or without chemotherapy.
This description comes directly from the study's public registry record.
Julie My Van Nguyen, MD · 905-521-2100 · nguyenjmv@HHSC.CA
Emily Di Sante, MA · 905-521-2100 · emily.disante@phri.ca
Always discuss trial participation with your own doctor first.
| Juravinksi Hospital | Hamilton, Ontario, Canada | Recruiting |
| Credit Valley Hospital | Mississauga, Ontario, Canada | Recruiting |
| Sunnybrook | Toronto, Ontario, Canada | Recruiting |
| University Health Network | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05738252